While the short-term mortality of sepsis has improved over the last decade, it still causes huge clinical impacts on health care system. Systemic inflammatory response, one of the key features in sepsis, is characterized by increased levels of various cytokines and chemokines in circulation and is significantly correlated with organ dysfunction and mortality. Therefore, circulatory cytokine profiling is essential in determining the severity of inflammatory responses in sepsis.
ELISA is a traditional way for measuring cytokine levels in biofluid samples which not only results in increased consumption of the precious clinical samples but also increases experimental workload, leading to potential experimental errors. MILLIPLEX® human cytokine assay is a bead-based technology for simultaneous detection of various cytokines in biofluid samples, through flow cytometry-based analysis. In comparison with conventional ELISA, MILLIPLEX® cytokine assay only requires a small volume of biofluid samples (up to 25 µl), thus preserving the limited clinical samples and shows highly enhanced performance, particularly the analytical sensitivity and increased dynamic range. Therefore, MILLIPLEX® cytokine assay is valuable for cytokine profiling in cohort studies of sepsis patients.
In this webinar, Dr. Chung will share his experience using MILLIPLEX® cytokine panels in characterizing sepsis-related systemic inflammation.
Key Learning Points:
- Why cytokine profiling is significant in characterizing systemic inflammation in sepsis
- How MILLIPLEX® human cytokine panels enhance profiling in sepsis research
- The correlation of cytokine profiling with the severity of organ dysfunction and mortality in sepsis
Speakers
Kuei-Pin Chung, Ph.D.
National Taiwan University Hospital, Department of Laboratory Medicine
Assistant Professor and Attending Physician
Dr. Chung’s specialties include internal medicine, pulmonary medicine, critical care medicine, and clinical pathology. As Assistant Professor in Laboratory Medicine at National Taiwan University Hospital, he focuses on altered metabolic and mitochondrial regulation in the pathogenesis of various pulmonary diseases and critical illnesses.
Anitaben Tailor, Ph.D.
Merck
Biology Technical Marketing
Anitaben Tailor brings over 10 years of immunoassay platform experience in the biopharmaceutical industry. After her post-doctoral fellowship, she held faculty positions at Johns Hopkins and NIH; then joined the industry in a global role with Merck's Life Science division. More recently, she focuses on the technical marketing of the Immunoassay portfolio within Pharma and CROs.
Research and disease areas
- Immunology research
Duration:1h
語言:English
會話 1:提出 June 24, 2022
若要繼續閱讀,請登入或建立帳戶。
還沒有帳戶?